Effectiveness of autologous serum as an alternative to fetal bovine serum in adipose-derived stem cell engineering

Cell and Tissue Banking

Volumn 14, Issue 3, 2013, Pages 413-422

  Choi, Jaehoon ^a   Chung, Jee Hyeok ^c   Kwon, Geun Yong ^d   Kim, Ki Wan ^b   Kim, Sukwha ^b   Chang, Hak ^b  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Profile Plastic Aesthetic Clinic   (South Korea)

^d Korea Centers for Disease Control and Prevention   (South Korea)

Author keywords

Adipogenic differentiation; Adipose derived stem cell; Autologous serum; Fetal bovine serum alternative

Indexed keywords

EID: 84881481791     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-012-9341-1     Document Type: Article

References (33)

1. Aust L, Devlin B, Foster SJ, Halvorsen YD, Hicok K, du Laney T, Sen A, Willingmyre GD, Gimble JM (2004) Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy 6:7-14
2. Baksh D, Song L, Tuan RS (2004) Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8:301-316
3. Bang OY, Lee JS, Lee PH, Lee G (2005) Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 57:874-882
4. Brunner D, Frank J, Appl H, Schöffl H, Pfaller W, Gstraunthaler G (2010) Serum-free cell culture: the serum-free media interactive online database. ALTEX 27:53-62
5. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M, Dragoo JL, Ashjian P, Thomas B, Benhaim P, Chen I, Fraser J, Hedrick MH (2003) Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174:101-109
6. Dedrick VA (1997) Determining the safety of medical devices containing animal tissues: the new European standards. J Regul Affairs Prof Soc 2:20
7. Dimarakis I, Levicar N (2006) Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 24:1407-1408
8. Dromard C, Bourin P, André M, De Barros S, Casteilla L, Planat-Benard V (2011) Human adipose derived stroma/stem cells grow in serum-free medium as floating spheres. Exp Cell Res 317:770-780
9. Euhus DM, Hudd C, LaRegina MC, Johnson FE (1986) Tumor measurement in the nude mouse. J Surg Oncol 31:229-234
10. Falkner E, Appl H, Eder C, Losert UM, Schöffl H, Pfaller W (2006) Serum free cell culture: the free access online database. Toxicol In Vitro 20:395-400
11. Honmou O, Houkin K, Matsunaga T et al (2011) Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 134:1790-1807
12. Kievits F, Boerenkamp WJ, Ivanyi P (1988) H-2-dependent binding of xenogeneic beta 2-microglobulin from culture media. J Immunol 140:4253-4255
13. Klein R, Dumble LJ (1993) Transmission of Creutzfeldt-Jakob disease by blood transfusion. Lancet 341:768
14. Kobayashi T, Watanabe H, Yanagawa T et al (2005) Motility and growth of human bone-marrow mesenchymal stem cells during ex vivo expansion in autologous serum. J Bone Joint Surg Br 87:1426-1433
15. Kocaoemer A, Kern S, Kluter H, Bieback K (2007) Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25:1270-1278
16. Koller MR, Maher RJ, Manchel I, Oxender M, Smith AK (1998) Alternatives to animal sera for human bone marrow cell expansion: human serum and serum-free media. J Hematother 7:413-423
17. Kuznetsov SA, Mankani MH, Robey PG (2000) Effect of serum on human bone marrow stromal cells: ex vivo expansion and in vivo bone formation. Transplantation 70:1780-1787
18. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, Ringdén O (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441
19. Mackensen A, Drager R, Schlesier M, Mertelsmann R, Lindemann A (2000) Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol Immunother 49:152-156
20. McCarty RC, Xian CJ, Gronthos S, Zannettino AC, Foster BK (2010) Application of autologous bone marrow derived mesenchymal stem cells to an ovine model of growth plate cartilage injury. Open Orthop J 23:204-210
21. Nimura A, Muneta T, Koga H, Mochizuki T, Suzuki K, Makino H, Umezawa A, Sekiya I (2008) Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Arthr Rheum 58:501-510
22. Oreffo RO, Virdi AS, Triffitt JT (1997) Modulation of osteogenesis and adipogenesis by human serum in human bone marrow cultures. Eur J Cell Biol 74:251-261
23. Pérez-Ilzarbe M, Diez-Campelo M, Aranda P, Tabera S, Lopez T, del Cañizo C, Merino J, Moreno C, Andreu EJ, Prósper F, Pérez-Simón JA (2009) Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Transfusion 49:1901-1910
24. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E, Marcacci M (2001) Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344:385-386
25. Shahdadfar A, Fronsdal K, Haug T, Reinholt FP, Brinchmann JE (2005) In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23:1357-1366
26. Spees JL, Gregory CA, Singh H, Tucker HA, Peister A, Lynch PJ, Hsu SC, Smith J, Prockop DJ (2004) Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cell for cell and gene therapy. Mol Ther 9:747-756
27. Stute N, Holtz K, Bubenheim M, Lange C, Blake F, Zander AR (2004) Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 32:1212-1225
28. Tomayko MM, Reynolds CP (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24:148-154
29. Vacanti CA, Bonassar LJ, Vacanti MP, Shufflebarger J (2001) Replacement of an avulsed phalanx with tissue-engineered bone. N Engl J Med 344:1511-1514
30. von Bonin M, Stölzel F, Goedecke A, Richter K, Wuschek N, Hölig K, Platzbecker U, Illmer T, Schaich M, Schetelig J, Kiani A, Ordemann R, Ehninger G, Schmitz M, Bornhäuser M (2009) Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant 43:245-251
31. Wakitami S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M (2002) Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthr Cartil 10:199-206
32. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921-925
33. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295